NEKTAR THERAPEUTICS — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B1
424B3
424B4
424B5
424B7
425
5
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
NTN 10K
POS AM
PRE 14A
REGDEX
RW
S-3
S-3/A
S-3ASR
S-8
S-8 POS
SC 13D
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001820 | Mar 27, 2026 | — |
| 144 | — | 0001959173-26-002286 | Mar 13, 2026 | — |
| 10-K | 10-K | 0001193125-26-104547 | Mar 13, 2026 | Dec 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-26-027026 | Mar 12, 2026 | — |
| SCHEDULE 13G | — | 0000315066-26-000649 | Mar 6, 2026 | — |
| 4 | 4 | 0001193125-26-061886 | Feb 20, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-061885 | Feb 20, 2026 | Feb 18, 2026 |
| 144 | — | 0001959173-26-001149 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001135 | Feb 18, 2026 | — |
| SCHEDULE 13G/A | — | 0001446580-26-000040 | Feb 13, 2026 | — |
| 8-K | 8-K | 0001193125-26-049378 | Feb 13, 2026 | Feb 11, 2026 |
| 424B5 | 424B5 | 0001193125-26-049191 | Feb 13, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-044760 | Feb 10, 2026 | — |
| 8-K | 8-K | 0001193125-26-044751 | Feb 10, 2026 | — |
| 8-K | 8-K | 0001193125-26-043755 | Feb 10, 2026 | — |
| SCHEDULE 13G | — | 0000102909-26-000212 | Jan 30, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-008210 | Jan 27, 2026 | — |
| 4 | 4 | 0001193125-26-019843 | Jan 22, 2026 | Jan 20, 2026 |
| 144 | — | 0001959173-26-000377 | Jan 20, 2026 | — |
| 4 | 4 | 0001193125-25-331189 | Dec 23, 2025 | Dec 22, 2025 |
| 4 | 4 | 0001193125-25-331187 | Dec 23, 2025 | Dec 22, 2025 |
| 8-K | 8-K | 0001193125-25-320009 | Dec 16, 2025 | — |
| 4 | 4 | 0001193125-25-297855 | Nov 25, 2025 | Nov 21, 2025 |
| 4 | 4 | 0001193125-25-297852 | Nov 25, 2025 | Nov 21, 2025 |
| 4 | 4 | 0001193125-25-297850 | Nov 25, 2025 | Nov 21, 2025 |
| 144 | — | 0001959173-25-007276 | Nov 25, 2025 | — |
| 144 | — | 0001959173-25-007275 | Nov 25, 2025 | — |
| 144 | — | 0001959173-25-007274 | Nov 25, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-113606 | Nov 21, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112619 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001193125-25-283066 | Nov 14, 2025 | — |
| SCHEDULE 13G | — | 0001446580-25-000123 | Nov 13, 2025 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-109222 | Nov 12, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-277570 | Nov 12, 2025 | — |
| S-3ASR | S-3ASR | 0001193125-25-277535 | Nov 12, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-107821 | Nov 10, 2025 | Nov 8, 2025 |
| 10-Q | 10-Q | 0001193125-25-270230 | Nov 7, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-107180 | Nov 6, 2025 | — |
| SCHEDULE 13G/A | — | 0000102909-25-000266 | Oct 31, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-103174 | Oct 28, 2025 | — |
| 4 | 4 | 0001193125-25-227237 | Oct 1, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001193125-25-227236 | Oct 1, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001193125-25-227235 | Oct 1, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001193125-25-227233 | Oct 1, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001193125-25-227232 | Oct 1, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-088792 | Sep 18, 2025 | — |
| 4 | 4 | 0000950170-25-114365 | Sep 11, 2025 | Sep 9, 2025 |
| 144 | — | 0001959173-25-005882 | Sep 9, 2025 | — |
| 4 | 4 | 0000950170-25-113692 | Sep 8, 2025 | Sep 4, 2025 |
| 4 | 4 | 0000950170-25-113691 | Sep 8, 2025 | Sep 4, 2025 |